- ¥10bn
- ¥6bn
- ¥15bn
- 99
- 76
- 43
- 86
Annual income statement for MedPeer, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,311 | 7,435 | 8,452 | 14,541 | 14,948 |
| Cost of Revenue | |||||
| Gross Profit | 3,506 | 4,855 | 5,034 | 6,867 | 6,872 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,206 | 5,652 | 7,388 | 13,538 | 12,596 |
| Operating Profit | 1,105 | 1,784 | 1,064 | 1,002 | 2,353 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,131 | 1,812 | 1,114 | 1,047 | 2,372 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 803 | 1,332 | 815 | 638 | 1,500 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 726 | 1,293 | 812 | 618 | 1,482 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 726 | 1,293 | 812 | 618 | 1,482 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 34.5 | 57.9 | 37.9 | 45.3 | 50.6 |
| Dividends per Share |